BAA2023-1 research area 004: development of in vitro diagnostics for biodefense, antimicrobial resistant infections (AMR), and emerging infectious diseases
Active Definitive Contract Awarded Last action
- Contract number
- 75N93024C00052
- Awardee
-
Clear Labs Inc. UEI DB92QMA4T9G5
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $2,443,961
Award facts
- Opportunity
-
- 2023 NIAID Omnibus Broad Agency Announcement Solicitation · HHSNIHNIAIDBAA20231 · Posted Jan 11, 2023
- Contract value 83% obligated
-
- $2,443,960.78 Current, with exercised options
- $2,957,000.00 Potential, with all options
- Completion date 93% complete
- Current and potential, with all options
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 10 offers Negotiated Proposal / Quote
- Pricing
- Cost No Fee
- Place of performance
- San Carlos, CA 94070, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Original award | $2,443,961 |
About this award
The National Institute of Allergy and Infectious Diseases awarded a $2.957 million definitive contract to Clear Labs Inc. for development of in vitro diagnostics for biodefense, antimicrobial resistant infections, and emerging infectious diseases on August 1, 2024.
The contract is priced as cost no fee. Place of performance is San Carlos, California. The originating solicitation (BAA2023-1, Research Area 004) was posted January 11, 2023 with a due date of April 11, 2023. The contract ceiling is $2.957 million with an ultimate completion date of December 31, 2026. No set-aside was used in this award.
Quick answers
Who was awarded contract 75N93024C00052?
75N93024C00052 was awarded to Clear Labs Inc. by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on August 1, 2024.
How much is contract 75N93024C00052 worth?
The government has obligated $2,443,961 on 75N93024C00052. Its potential value, with all options, is $2,957,000.
Was contract 75N93024C00052 competed?
The extent of competition for 75N93024C00052 was full and open competition. The government received 10 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award